Last Updated: Thursday, June 05, 2014, 16:01
According to US Food and Drug Administration (USFDA), Wockhardt USA Inc, a subsidiary of Mumbai-based firm is voluntarily recalling 8,712 bottles of the drug in the American market.
Last Updated: Tuesday, June 03, 2014, 17:57
The US Food and Drug Administration has found as many as 12 procedural lapses in drug maker Wockhardt's US facility in Illinois.
Last Updated: Tuesday, May 27, 2014, 16:20
Wockhardt`s biggest market and the FDA has already banned the import of generic drugs from its two plants in India, citing quality lapses in the manufacturing process.
Last Updated: Thursday, May 08, 2014, 20:52
Indian pharmaceutical exports to the US is expected to keep growing despite a spate of import alerts issued by the US Food and Drug Administration (US FDA) in 2013, according to India Ratings & Research (Ind-Ra) report here.
Last Updated: Friday, April 25, 2014, 00:24
US regulators proposed new restrictions today on the soaring 2 billion USD market in e-cigarettes, which until now have been free from federal oversight.
Last Updated: Thursday, April 17, 2014, 17:54
Glenmark Pharmaceuticals is voluntarily recalling 2,904 bottles of Rantidine Tablets, used to treat ulcers of the stomach and intestines, in the US market, according to the US Food and Drug Administration.
Last Updated: Tuesday, March 18, 2014, 11:31
India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.
Last Updated: Thursday, March 13, 2014, 14:23
The US Food and Drug Administration (FDA) announced an "import alert" late Wednesday on drugs made by Sun at one of its plants in western India over failure to meet "good manufacturing practices".
Last Updated: Tuesday, February 18, 2014, 22:32
The US Food and Drug Administration (USFDA) today said it was working with regulators here to enhance the quality and safety of drugs as 40 per cent of generic drugs exported to America were from India.
Last Updated: Monday, February 10, 2014, 19:51
The matter came up during a meeting here between Commerce and Industry Minister Anand Sharma and US Food and Drug Administration (USFDA) Commissioner Margaret A Hamburg.
Last Updated: Monday, February 10, 2014, 10:21
In November, the U.S. Food and Drug Administration issued an import alert, effectively a ban, against Wockhardt's Chikalthana plant in western India.
Last Updated: Wednesday, February 05, 2014, 19:36
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore towards the financial impact of a US ban on import of products made at its plant at Toansa.
more videos >>